BioLife Solutions Inc (BLFS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioLife Solutions Inc (BLFS) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-491.00K) by net assets ($372.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioLife Solutions Inc (BLFS) net asset quality to measure how much of total assets are equity-financed.
BioLife Solutions Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how BioLife Solutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is BioLife Solutions Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
BioLife Solutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioLife Solutions Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wüstenrot & Württembergische AG
XETRA:WUW
|
0.198x |
|
Browave
TWO:3163
|
0.043x |
|
Genimous Technology Co Ltd
SHE:000676
|
0.013x |
|
Brim hf
IC:BRIM
|
-0.005x |
|
Navigator Holdings Ltd
NYSE:NVGS
|
0.038x |
|
I-Chiun Precision Industry Co Ltd
TW:2486
|
0.023x |
|
Zhongsheng Group Holdings Limited
F:5Z0
|
0.040x |
|
PT Sarana Menara
JK:TOWR
|
0.152x |
Annual Cash Flow Conversion Efficiency for BioLife Solutions Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of BioLife Solutions Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BioLife Solutions Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $371.89 Million | $20.11 Million | 0.054x | +123.84% |
| 2024-12-31 | $348.91 Million | $8.43 Million | 0.024x | +165.28% |
| 2023-12-31 | $337.66 Million | $-12.50 Million | -0.037x | -58.79% |
| 2022-12-31 | $364.19 Million | $-8.49 Million | -0.023x | -129.61% |
| 2021-12-31 | $476.37 Million | $-4.84 Million | -0.010x | -131.98% |
| 2020-12-31 | $205.25 Million | $6.51 Million | 0.032x | +117.27% |
| 2019-12-31 | $83.03 Million | $1.21 Million | 0.015x | -73.15% |
| 2018-12-31 | $43.15 Million | $2.35 Million | 0.054x | -9.23% |
| 2017-12-31 | $10.09 Million | $605.00K | 0.060x | +104.39% |
| 2016-12-31 | $3.17 Million | $-4.33 Million | -1.367x | -170.91% |
| 2015-12-31 | $9.86 Million | $-4.97 Million | -0.504x | -122.32% |
| 2014-12-31 | $13.94 Million | $-3.16 Million | -0.227x | -1962.55% |
| 2013-12-31 | $-13.27 Million | $146.01K | -0.011x | +83.93% |
| 2012-12-31 | $-12.49 Million | $854.93K | -0.068x | -177.33% |
| 2011-12-31 | $-11.18 Million | $-989.92K | 0.089x | -32.50% |
| 2010-12-31 | $-9.55 Million | $-1.25 Million | 0.131x | -57.46% |
| 2009-12-31 | $-7.83 Million | $-2.41 Million | 0.308x | -24.55% |
| 2008-12-31 | $-5.17 Million | $-2.11 Million | 0.409x | -62.74% |
| 2007-12-31 | $-2.47 Million | $-2.71 Million | 1.097x | +127.74% |
| 2006-12-31 | $180.09K | $-712.20K | -3.955x | +73.60% |
| 2005-12-31 | $38.48K | $-576.33K | -14.977x | -1882.23% |
| 2004-12-31 | $612.96K | $515.10K | 0.840x | +233.41% |
| 2003-12-31 | $1.36 Million | $-854.23K | -0.630x | -113.04% |
| 2002-12-31 | $-554.25K | $-2.68 Million | 4.831x | +156.81% |
| 2001-12-31 | $310.77K | $-2.64 Million | -8.504x | -964.52% |
| 2000-12-31 | $3.63 Million | $-2.90 Million | -0.799x | -145.54% |
| 1999-12-31 | $818.40K | $-266.26K | -0.325x | -1699.60% |
| 1998-12-31 | $1.43 Million | $29.12K | 0.020x | +103.35% |
| 1997-12-31 | $2.46 Million | $-1.49 Million | -0.608x | -17.07% |
| 1996-12-31 | $3.99 Million | $-2.07 Million | -0.519x | -34.00% |
| 1995-12-31 | $3.98 Million | $-1.54 Million | -0.387x | 0.00% |
| 1994-12-31 | $3.98 Million | $-1.54 Million | -0.387x | +21.05% |
| 1993-12-31 | $5.30 Million | $-2.60 Million | -0.491x | +67.30% |
| 1992-12-31 | $5.60 Million | $-8.40 Million | -1.500x | -318.60% |
| 1991-12-31 | $12.00 Million | $-4.30 Million | -0.358x | +21.17% |
| 1990-12-31 | $5.50 Million | $-2.50 Million | -0.455x | -15.38% |
| 1989-12-31 | $3.30 Million | $-1.30 Million | -0.394x | -- |
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more